DENVER, CO, Feb. 4 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH.OB) www.mitneedlefree.com MIT is pleased to announce the nomination of Mr. Harold Gervais as the 3rd member to join the newly-formed Advisory Board. Furthermore, Mr. Gervais will also hold the position of Vice-President and Chief Financial
Mr. Harold Gervais, MBA, has more than 25 years of experience in managing businesses of all sizes. He was Executive Vice President and CFO of ABB Canada and CIO of ABB Americas. ABB is one of the world's leader in power and automation engineering company with revenues of 35Bn in 2008.
Moreover, Mr. Gervais has held financial and human resources management position at Kimberly-Clark. Kimberly Clark is leading the world in essentials for a better life with revenues of 19.1 Bn in 2009.
Mr. Gervais completed many integration projects, realized the restructuring of different organizations and the optimization of different accounting systems. He has also completed several turnaround and financing mandates. Throughout the years he has developed an expertise for the creation and the execution of realistic action plans that deliver expected results. He currently sits on the board of directors of several companies.
The nomination and acceptance by Mr. Harold Gervais to join MIT's Advisory Board and his assuming the position of Vice-President and Chief Financial Officer of Medical International Technology Inc. will strengthen MIT's management team. The addition of Mr. Gervais serves to better control the company's overall operations, including the Chinese Joint Venture, in order to reach our objectives in sales and profits for the coming years.
Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.
About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.
The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All